Loading
CP
ChengDa Pharmaceuticals Co., Ltd. Stock: price and insider trades · China
诚达药业
ChengDa Pharmaceuticals Co., Ltd.: what insiders have been doing
Insider filings for ChengDa Pharmaceuticals Co., Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 21 January 2022. This page will fill in as new trades are disclosed. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€10,242
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,922 of 24,148 companies
38.2
score / 100
Value32
Quality45
FCF yld-0.8%
Earn yld-0.3%
EV/EBITDA·
ROE-1.1%
Gross mgn44%
Net mgn-2.9%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥28.34
Analyst consensus
Income statement
RevenueCN¥406.4M
Gross profitCN¥179.5M44% margin
EBITDACN¥62M15% margin
Net income-CN¥11.9M-4.7% margin
Valuation
P/Book2.0x
Beta-0.18
Balance sheet & cash
Market capCN¥4.4B
Total debtCN¥59.1M
Free Cash Flow-CN¥35M
Debt / Equity2%
Profitability & ownership
ROE-1.1%
ROA-0.6%
% insiders49.3%
% institutions3.2%
Last declaration on 21 January 2022
About ChengDa Pharmaceuticals Co., Ltd.
Chengda Pharmaceutical is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative medicines.
